Houlihan Lokey, Inc.
HLINYSECIK 1302215Financial / Asset Managementfiscal year ends March51 quarters since 2014
Latest quarter Q2 FY2027, filed October 30, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q3 FY2023 to Q2 FY2027, through the filing of October 30, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q2 FY2027 filed October 30, 2026.
| Millions of dollars | Q2 FY2027ended Sep 30, 2026filed Oct 30, 2026 | Q1 FY2027ended Jun 30, 2026filed Jul 31, 2026 | Q4 FY2026ended Mar 31, 2026filed May 22, 2026 | Q3 FY2026ended Dec 31, 2025filed Feb 3, 2026 | Q2 FY2026ended Sep 30, 2025filed Nov 4, 2025 | Q1 FY2026ended Jun 30, 2025filed Aug 5, 2025 | Q4 FY2025ended Mar 31, 2025filed May 15, 2025 | Q3 FY2025ended Dec 31, 2024filed Feb 4, 2025 | YoYQ2 FY2027vs Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 692 | 511 | 636 | 717 | 660 | 605 | 666 | 634 | +4.8% |
| Cost of revenue | — | — | — | — | — | — | — | — | — |
| Gross profit | 239 | 154 | — | 231 | 222 | 188 | 226 | 199 | +7.7% |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | — | — | — | — | — | — | — | — | — |
| Operating income | 154 | 78 | 125 | 161 | 151 | 90 | 141 | 136 | +2.0% |
| Other income (expense) | 5 | 8 | 9 | 9 | 9 | 8 | 9 | 9 | −44.4% |
| Pretax income | 159 | 86 | 135 | 170 | 160 | 98 | 150 | 145 | −0.6% |
| Income tax | 49 | 8 | 36 | 53 | 49 | 0 | 28 | 50 | 0.0% |
| Net income | 109 | 78 | 100 | 117 | 111 | 98 | 122 | 95 | −1.8% |
| Diluted EPS ($) | 1.64 | 1.15 | — | 1.70 | 1.63 | 1.42 | — | 1.39 | +0.6% |
| Diluted shares (millions) | 67 | 68 | — | 68 | 69 | 69 | — | 69 | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q2 FY2027 filed October 30, 2026.
| Millions of dollars | Q2 FY2027ended Sep 30, 2026filed Oct 30, 2026 | Q1 FY2027ended Jun 30, 2026filed Jul 31, 2026 | Q4 FY2026ended Mar 31, 2026filed May 22, 2026 | Q3 FY2026ended Dec 31, 2025filed Feb 3, 2026 | Q2 FY2026ended Sep 30, 2025filed Nov 4, 2025 | Q1 FY2026ended Jun 30, 2025filed Aug 5, 2025 | Q4 FY2025ended Mar 31, 2025filed May 15, 2025 | Q3 FY2025ended Dec 31, 2024filed Feb 4, 2025 | YoYQ2 FY2027vs Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 837 | 745 | 1,189 | 1,056 | 924 | 794 | 971 | 799 | −9.4% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — |
| Total assets | 3,975 | 3,717 | 4,309 | 3,937 | 3,793 | 3,518 | 3,820 | 3,476 | +4.8% |
| Total current liabilities | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Total liabilities | 1,557 | 1,352 | 1,856 | 1,643 | 1,546 | 1,340 | 1,645 | 1,395 | +0.7% |
| Stockholders’ equity | 2,307 | 2,255 | 2,342 | — | 2,247 | 2,178 | 2,175 | — | +2.7% |
| Shares outstanding (millions) | — | — | — | — | — | — | — | — | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q2 FY2027 filed October 30, 2026.
| Millions of dollars | Q2 FY2027ended Sep 30, 2026filed Oct 30, 2026 | Q1 FY2027ended Jun 30, 2026filed Jul 31, 2026 | Q4 FY2026ended Mar 31, 2026filed May 22, 2026 | Q3 FY2026ended Dec 31, 2025filed Feb 3, 2026 | Q2 FY2026ended Sep 30, 2025filed Nov 4, 2025 | Q1 FY2026ended Jun 30, 2025filed Aug 5, 2025 | Q4 FY2025ended Mar 31, 2025filed May 15, 2025 | Q3 FY2025ended Dec 31, 2024filed Feb 4, 2025 | YoYQ2 FY2027vs Q2 FY2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 252 | (336) | 293 | 218 | 325 | (132) | 358 | 266 | −22.5% |
| Capital expenditures | 12 | 6 | 6 | 1 | 2 | 13 | 14 | 4 | +500.0% |
| Free cash flow (CFO − capex) | 240 | (342) | 287 | 217 | 323 | (145) | 344 | 262 | −25.7% |
| Depreciation and amortization | 10 | 8 | 8 | 8 | 10 | 16 | 15 | 10 | 0.0% |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Dividends paid | 46 | 61 | 39 | 41 | 41 | 53 | 39 | 37 | +12.2% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2026 filed May 22, 2026.
Income statement
| Millions of dollars | FY2026ended Mar 31, 2026filed May 22, 2026 | FY2025ended Mar 31, 2025filed May 15, 2025 | FY2024ended Mar 31, 2024filed May 21, 2024 | FY2023ended Mar 31, 2023filed May 25, 2023 | FY2022ended Mar 31, 2022filed May 27, 2022 | FY2021ended Mar 31, 2021filed May 21, 2021 | FY2020ended Mar 31, 2020filed May 15, 2020 | FY2019ended Mar 31, 2019filed May 24, 2019 | FY2018ended Mar 31, 2018filed May 25, 2018 | FY2017ended Mar 31, 2017filed Jun 13, 2017 | FY2016ended Mar 31, 2016filed Jun 23, 2016 | FY2015ended Mar 31, 2015filed Nov 13, 2015 | FY2014ended Mar 31, 2014filed Nov 13, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,618 | 2,389 | 1,914 | 1,809 | 2,270 | 1,525 | 1,159 | 1,084 | 963 | 872 | 694 | 681 | 592 |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Gross profit | — | 772 | 571 | 557 | 795 | 521 | 323 | 306 | 278 | 241 | 189 | 178 | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | 527 | 503 | 373 | 342 | 613 | 408 | 230 | 219 | 214 | 182 | 126 | 129 | 103 |
| Other income (expense) | 35 | 29 | 17 | (18) | (9) | 1 | 6 | 5 | 3 | (4) | (1) | 3 | 2 |
| Pretax income | 562 | 531 | 391 | 324 | 604 | 409 | 236 | 224 | 218 | 178 | 126 | 132 | 105 |
| Income tax | 138 | 132 | 110 | 70 | 166 | 96 | 52 | 65 | 46 | 70 | 56 | 52 | 44 |
| Net income | 426 | 400 | 280 | 254 | 438 | 313 | 184 | 159 | 172 | 108 | 70 | 80 | 61 |
| Diluted EPS ($) | 6.22 | 5.82 | 4.11 | 3.76 | 6.41 | 4.55 | 2.80 | 2.42 | 2.60 | 1.63 | 1.10 | 1.33 | 1.05 |
| Diluted shares (millions) | 68 | 69 | 68 | 68 | 68 | 69 | 66 | 66 | 66 | 67 | 63 | 60 | 58 |
Balance sheet
| Millions of dollars | FY2026ended Mar 31, 2026filed May 22, 2026 | FY2025ended Mar 31, 2025filed May 15, 2025 | FY2024ended Mar 31, 2024filed May 21, 2024 | FY2023ended Mar 31, 2023filed May 25, 2023 | FY2022ended Mar 31, 2022filed May 27, 2022 | FY2021ended Mar 31, 2021filed May 21, 2021 | FY2020ended Mar 31, 2020filed May 15, 2020 | FY2019ended Mar 31, 2019filed May 24, 2019 | FY2018ended Mar 31, 2018filed May 25, 2018 | FY2017ended Mar 31, 2017filed Jun 13, 2017 | FY2016ended Mar 31, 2016filed Jun 23, 2016 | FY2015ended Mar 31, 2015filed Nov 13, 2015 | FY2014ended Mar 31, 2014filed Nov 13, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,189 | 971 | 721 | 714 | 834 | 847 | 380 | 286 | 207 | 300 | 166 | 89 | 109 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | 4,309 | 3,820 | 3,171 | 2,969 | 2,887 | 2,426 | 1,677 | 1,426 | 1,424 | 1,386 | 1,071 | 1,230 | 1,061 |
| Total current liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | 56 | 37 | 31 | 12 | 33 | 77 | — | — |
| Total liabilities | 1,856 | 1,645 | 1,334 | 1,356 | 1,443 | 1,043 | 693 | 535 | 566 | 655 | 417 | 404 | — |
| Stockholders’ equity | 2,342 | 2,175 | — | — | — | — | — | — | — | — | 651 | 823 | — |
| Shares outstanding (millions) | — | — | — | — | — | — | — | — | — | — | — | — | — |
Cash flow statement
| Millions of dollars | FY2026ended Mar 31, 2026filed May 22, 2026 | FY2025ended Mar 31, 2025filed May 15, 2025 | FY2024ended Mar 31, 2024filed May 21, 2024 | FY2023ended Mar 31, 2023filed May 25, 2023 | FY2022ended Mar 31, 2022filed May 27, 2022 | FY2021ended Mar 31, 2021filed May 21, 2021 | FY2020ended Mar 31, 2020filed May 15, 2020 | FY2019ended Mar 31, 2019filed May 24, 2019 | FY2018ended Mar 31, 2018filed May 25, 2018 | FY2017ended Mar 31, 2017filed Jun 13, 2017 | FY2016ended Mar 31, 2016filed Jun 23, 2016 | FY2015ended Mar 31, 2015filed Nov 13, 2015 | FY2014ended Mar 31, 2014filed Nov 13, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 704 | 849 | 328 | 136 | 737 | 580 | 288 | 224 | 251 | 252 | 12 | 197 | 165 |
| Capital expenditures | 22 | 40 | 67 | 51 | 9 | 14 | 21 | 7 | 8 | 14 | 9 | 5 | 2 |
| Free cash flow (CFO − capex) | 682 | 809 | 262 | 86 | 728 | 566 | 267 | 218 | 243 | 238 | 2 | 192 | 163 |
| Depreciation and amortization | 43 | 41 | 29 | 58 | 49 | 15 | 17 | 14 | 8 | 9 | 7 | 6 | 6 |
| Share repurchases | 175 | 53 | 25 | 49 | 305 | 102 | 30 | 70 | 18 | 0 | 0 | — | — |
| Dividends paid | 174 | 165 | 148 | 140 | 115 | 92 | 81 | 67 | 52 | 55 | 114 | 2 | 1 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Reichert Thomas | Director | award | 925 | $0.00 | — | 925 | Oct 2, 2026 |
| Sep 10, 2026 | Crain Christopher M | GENERAL COUNSEL | conversion | 1,000 | $0.00 | — | 1,000 | Sep 10, 2026 |
| Sep 10, 2026 | Crain Christopher M | GENERAL COUNSEL | open-market sale | 1,000 | $140.15 | $140K | 0 | Sep 10, 2026 |
| Aug 3, 2026 | Alley J Lindsey | Chief Financial Officer | open-market buy | 4,020 | $124.52 | $501K | 4,020 | Aug 5, 2026 |
| May 21, 2026 | Beiser Scott L | CO-CHAIRMAN, Director, 10% owner | conversion | 6,265 | $0.00 | — | 6,265 | May 21, 2026 |
| May 21, 2026 | Beiser Scott L | CO-CHAIRMAN, Director, 10% owner | open-market sale | 6,265 | $150.26 | $941K | 0 | May 21, 2026 |
| May 21, 2026 | Walker Cyrus D. | Director | award | 996 | $0.00 | — | 7,111 | May 21, 2026 |
| May 21, 2026 | Bassey Ekpedeme M | Director | award | 797 | $0.00 | — | 6,424 | May 21, 2026 |
| May 21, 2026 | Zucker Gillian Beth | Director | award | 996 | $0.00 | — | 6,529 | May 21, 2026 |
| May 21, 2026 | Zuber Paul Andrew | Director | awardindirect | 797 | $0.00 | — | 7,005 | May 21, 2026 |
| May 21, 2026 | Schriesheim Robert A | Director | award | 1,129 | $0.00 | — | 29,111 | May 21, 2026 |
| May 21, 2026 | Mund Ronald Scott | Director | award | 476 | $0.00 | — | 969 | May 21, 2026 |
| Apr 1, 2026 | Crain Christopher M | GENERAL COUNSEL | conversion | 500 | $0.00 | — | 500 | Apr 2, 2026 |
| Apr 1, 2026 | Crain Christopher M | GENERAL COUNSEL | open-market sale10b5-1 | 500 | $143.40 | $72K | 0 | Apr 2, 2026 |
| Feb 6, 2026 | Schriesheim Robert A | Director | open-market sale | 5,000 | $170.86 | $854K | 27,982 | Feb 10, 2026 |
| Jan 2, 2026 | Crain Christopher M | GENERAL COUNSEL | open-market sale10b5-1 | 500 | $174.17 | $87K | 0 | Jan 5, 2026 |
| Jan 2, 2026 | Crain Christopher M | GENERAL COUNSEL | conversion | 500 | $0.00 | — | 500 | Jan 5, 2026 |
| Dec 5, 2025 | Gold Irwin | CO-CHAIRMAN, Director, 10% owner | gift | 5,000 | $0.00 | — | 0 | Dec 8, 2025 |
| Dec 5, 2025 | Gold Irwin | CO-CHAIRMAN, Director, 10% owner | conversion | 5,000 | $0.00 | — | 5,000 | Dec 8, 2025 |
| Nov 26, 2025 | Crain Christopher M | GENERAL COUNSEL | gift | 1,200 | $0.00 | — | 0 | Dec 1, 2025 |
| Nov 26, 2025 | Crain Christopher M | GENERAL COUNSEL | conversion | 1,200 | $0.00 | — | 1,200 | Dec 1, 2025 |
| Nov 10, 2025 | Beiser Scott L | CO-CHAIRMAN, Director, 10% owner | conversion | 8,000 | $0.00 | — | 8,000 | Nov 12, 2025 |
| Nov 10, 2025 | Beiser Scott L | CO-CHAIRMAN, Director, 10% owner | gift | 8,000 | $0.00 | — | 0 | Nov 12, 2025 |
| Oct 1, 2025 | Mund Ronald Scott | Director | award | 483 | $0.00 | — | 483 | Oct 14, 2025 |
| Sep 16, 2025 | Gold Irwin | CO-CHAIRMAN, Director, 10% owner | conversion | 6,811 | $0.00 | — | 6,811 | Sep 18, 2025 |
Full insider history for Houlihan Lokey, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held HLI in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded HLI by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Baron Capital Group | Ron Baron | Q2 2026 | $117M | 869,544 | 0.18% | trimmed −18.1% |
Sources
Fiscal year ends in month 3; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- Houlihan Lokey, Inc., CIK 1302215 on EDGAR
- Extract generated
- November 8, 2026
- Withheld
- 5 line-years whose four quarters do not sum to the filed year: net income FY2017, operating income FY2017, net income FY2018, operating income FY2018, income tax FY2019
- Repaired
- 1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2021
XBRL concepts behind each line
Income statement
ContractsRevenue, RevenueFromContractWithCustomerExcludingAssessedTaxGrossProfitOperatingIncomeLossNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLoss, NetIncomeLossAvailableToCommonStockholdersBasicEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsLongTermDebtLiabilitiesStockholdersEquityCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsThe data
The statements on this page as files, generated November 8, 2026.
- JSON file
/data/financials/HLI.json